AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Amlodipine Besylate Equivalent To Amlodipine
133 registrations across 1 African market— 123 active
Markets with Amlodipine Besylate Equivalent To Amlodipine
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CALSAR CO 101/160/25 mg | 🇿🇦South Africa | Pharma Dynamics (Pty) Ltd | active | Mar 2030 |
| CALSAR CO 101/320/25 mg | 🇿🇦South Africa | Pharma Dynamics (Pty) Ltd | active | Mar 2030 |
| CALSAR CO 5/160/25 mg | 🇿🇦South Africa | Pharma Dynamics (Pty) Ltd | active | Mar 2030 |
| CALSAR CO 10/160/12,5 mg | 🇿🇦South Africa | Pharma Dynamics (Pty) Ltd | active | Mar 2030 |
| CALSAR CO 5/160/12,5 mg | 🇿🇦South Africa | Pharma Dynamics (Pty) Ltd | active | Mar 2030 |
| VALDUO 5/320 | 🇿🇦South Africa | Forrester Pharma (Pty) Ltd | active | Mar 2030 |
| VALDUO 10/320 | 🇿🇦South Africa | Forrester Pharma (Pty) Ltd | active | Mar 2030 |
| VALDOU 10/160 | 🇿🇦South Africa | Forrester Pharma (Pty) Ltd | active | Sept 2029 |
| VALDOU 5/160 | 🇿🇦South Africa | Forrester Pharma (Pty) Ltd | active | Sept 2029 |
| VALDOU 5/80 | 🇿🇦South Africa | Forrester Pharma (Pty) Ltd | active | Sept 2029 |
| DIPTATRIS 10 mg/320 mg/25 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Feb 2029 |
| MAVATRIS 5 mg/160 mg/12,5 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Feb 2029 |
| CHLOVAMAL 10 mg/160 mg/25 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Feb 2029 |
| MAVATRIS 10 mg/160 mg/12,5 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Feb 2029 |
| DIPTATRIS 5 mg/160 mg/ 25 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Feb 2029 |
| CHLOVAMAL10 mg/160 mg/12,5 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Feb 2029 |
| MAVATRIS 10 mg/160 mg/25 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Feb 2029 |
| MAVATRIS 10 mg/320 mg/25 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Feb 2029 |
| CHLOVAMAL 10 mg/320 mg/25 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Feb 2029 |
| CHLOVAMAL 5 mg/160 mg/25 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Feb 2029 |
| DIPTATRIS 10 mg/160 mg/ 25 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Feb 2029 |
| MAVATRIS 5 mg/160 mg/25 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Feb 2029 |
| CHLOVAMAL 5 mg/160 mg/12,5 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Feb 2029 |
| DIPTATRIS 5 mg/160 mg/ 12,5 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Feb 2029 |
| DIPTATRIS 10 mg/160 mg/ 12,5 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Feb 2029 |
| KYRILOK TABLETS 5/160/12,5 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Dec 2028 |
| KYRILOK TABLETS 5/160/25 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Dec 2028 |
| KYRILOK TABLETS 10/320/25 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Dec 2028 |
| ARLOZYB CO TABLETS 5/160/12,5 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Dec 2028 |
| KYRILOK TABLETS 10/160/25 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Dec 2028 |
| KYRILOK TABLETS 10/160/12,5 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Dec 2028 |
| ARLOZYB CO TABLETS 10/160/12,5 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Dec 2028 |
| ARLOZYB CO TABLETS 10/160/25 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Dec 2028 |
| ARLOZYB CO TABLETS 10/320/25 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Dec 2028 |
| ARLOZYB CO TABLETS 5/160/25 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Dec 2028 |
| CALBLOC 5 | 🇿🇦South Africa | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | Jul 2026 |
| CALBLOC 10 | 🇿🇦South Africa | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | Jul 2026 |
| STYTEM 80/10 | 🇿🇦South Africa | Activo Health (Pty) Ltd | active | Nov 2025 |
| HIPERVAL 10/160 | 🇿🇦South Africa | Innovata Pharmaceuticals | suspended | Dec 2024 |
| HIPERVAL 5/160 | 🇿🇦South Africa | Innovata Pharmaceuticals | suspended | Dec 2024 |
| DAFIRO 10/320 mg | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | suspended | Mar 2024 |
| APEX-AMLODIPINE 5 mg | 🇿🇦South Africa | Camox Pharmaceuticals (Pty) Ltd | suspended | Apr 2023 |
| AMLOPRESS 5 mg | 🇿🇦South Africa | Camox Pharmaceuticals (Pty) Ltd | suspended | Apr 2023 |
| APEX-AMLODIPINE 10 mg | 🇿🇦South Africa | Camox Pharmaceuticals (Pty) Ltd | suspended | Apr 2023 |
| AMLOPRESS 10 mg | 🇿🇦South Africa | Camox Pharmaceuticals (Pty) Ltd | suspended | Apr 2023 |
| KLODIP-5 | 🇿🇦South Africa | Teva Pharmaceuticals (Pty) Ltd | suspended | Mar 2023 |
| PENDINE 10 | 🇿🇦South Africa | Unichem SA (Pty) Ltd | active | Jan 1900 |
| CADUET 10 mg/40 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Jan 1900 |
| ADCO-NORPENE 5 mg | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| AMLODIPINE UNICORN 5 | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | active | Jan 1900 |
Showing 50 of 133 registrations. Sign up free to search and export all.
Amlodipine Besylate Equivalent To Amlodipine in Africa — Regulatory Overview
Amlodipine Besylate Equivalent To Amlodipine is registered across 1 African markets with 133 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 133 registrations, 123 (92%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.